Recent Finacing
Recent Raise
Heat Biologics develops off-the-shelf, non–patient-specific immunotherapies reprogramming tumor cells to secrete antigens and stimulate immune responses; lead program in Phase 2 lung cancer, Phase 1 planned for bladder, ovarian.
Focus Areas
Total Raised
Funding round